A study from an RPB-supported researcher at Northwestern University School of Medicine could speed up the diagnosis of retinal diseases.
Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.
The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
RPB-supported researchers make progress in characterizing the genetic components of Usher syndrome.
The findings may have significant therapeutic implications for AMD, the most common cause of elderly blindness in the developed world
At the ARVO Inaugural Press Conference, three RPB-funded scientists pushing the boundaries of imaging, early detection, regeneration.
A finding that opens the door to improving retinal prosthetic devices, targeting treatments to restore damaged retinal circuits, and improving early detection of retinal diseases.
View can help researchers understand how the brain’s connectivity is disrupted in mental and neurological conditions such as schizophrenia, depression, anxiety, autism and in vision-related conditions.
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|